Infection with human T lymphotropic virus type I in organ transplant donors and recipients in Spain

Journal of Medical Virology

Volumn 76, Issue 2, 2005, Pages 268-270

  Toro, Carlos ^a   Benito, Rafael ^b   Aguilera, Antonio ^c   Bassani, Sylvina ^a   Rodríguez, Carmen ^d   Calderón, Enrique ^e   Caballero, Estrella ^f   Alvarez, Patricia ^g   García, Juan ^h   Rodríguez Iglesias, Manuel ⁱ   Guelar, Ana ^j   Del Romero, Jorge ^d   Soriano, Vincent ^a,k  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^c HOSPITAL XERAL CALDE   (Spain)

^d CENTRO SANITARIO SANDOVAL   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^g Service of Microbiology   (Spain)

^h Hospital Cristal Pinor   (Spain)

ⁱ HOSPITAL UNIVERSITARIO DE PUERTO REAL   (Spain)

^j HOSPITAL DEL MAR   (Spain)

^k NONE   (Spain)

more..

Author keywords

HTLV; Screening; Transplantation

Indexed keywords

VIRUS ANTIBODY;

ADULT; ANTIBODY SCREENING; ARTICLE; CLINICAL FEATURE; ENDEMIC DISEASE; EUROPE; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMIGRANT; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; ORGAN TRANSPLANTATION; SCREENING TEST; SERODIAGNOSIS; SPAIN; SPINAL CORD DISEASE; SYMPTOM; VIRUS INFECTION;

HTLV-I ANTIBODIES; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; SEROEPIDEMIOLOGIC STUDIES; SPAIN; TISSUE DONORS; TRANSPLANTATION;

EID: 20944443405     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20331     Document Type: Article

References (19)

1. Edlich R, Arnette J, Williams F. 2000. Global epidemic of Human T-cell lymphotropic virus type-I (HTLV-I). J Emerg Med 18:109-119.
2. The HTLV European Research Network. 1996. Seroepidemiology of the human T-cell leukaemia/lymphoma viruses in Europe. J Acquir Immune Defic Syndr 13:68-77.
3. Jacobson S, Lehky T, Nishimura M, Robinson S, McFarlin DE, Dhib-Jalbut S. 1993. Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis. Ann Neurol 33:392-396.
4. Jenks PJ, Barrett WY, Raftery MJ, Kelsey SM, van der Walt JD, Kon SP, Breuer J. 1995. Development of human T-cell lymphotropic virus type I-associated adult T-cell leukemia/lymphoma during immunosuppressive treatment following renal transplantation. Clin Infect Dis 21:992-993.
5. Mangano AM. 2003. Personal communication.
6. Manns A, Hisada M, La Grenade L. 1999. Human T-lymphotropic virus type I infection. Lancet 353:1951-1958.
7. Mate G, Gonzalez C, Bronsoms JM, Valles M, Torguet P, Mauri JM. 1995. Transplant and organ donor-associated transmission of Human T-lymphotropic virus types I and II. Transplant Proc 27:2417.
8. Nakamura N, Arakaki Y, Sunagawa H, Shiohira Y, Uehara H, Miyasato T, Koyama Y, Ogawa Y, Kowatari T. 1998. Influence of immunosuppression in HTLV-1-positive renal transplant recipients. Transplant Proc 30:1324-1326.
9. Nakatsuji Y, Sugai F, Watanabe S, Kaido M, Koguchi K, Abe K, Sakoda S. 2000. HTLV-I-associated myelopathy manifested after renal transplantation. J Neurol Sci 177:154-156.
10. Orland J, Engstrom J, Fridey J, Sacher RA, Smith JW, Nass C, Garratty G, Newman B, Smith D, Wang B, Loughlin K, Murphy EL, HTLV Outcomes Study. 2003. Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology 61:1588-1594.
11. Remesar MC, del Pozo AE, Pittis MG, Mangano AM, Sen L, Briones L. 2000. Transmission of HTLV-I by kidney transplant. Transfusion 40:1421-1422.
12. Shames B, D'Alessandro A, Sollinger H. 2002. Human T-cell lymphotrophic virus infection in organ donors: A need to reassess policy? Am J Transplant 2:658-663.
13. Tanabe K, Kitani R, Takahashi K, Tokumoto T, Ishikawa N, Oshima T, Kanematsu A, Fuchinoue S, Yagisawa T, Ota K, Toma H. 1998. Long-term results in human T-cell leukemia virus type 1-positive renal transplant recipients. Transplant Proc 30:3168-3170.
14. Taylor G, The HTLV European Research Network (HERN). 1999. The epidemiology and clinical impact of HTLV infections in Europe. AIDS Rev 1:195-204.
15. Toro C, Soriano V, Tuset C, Aguilera A, Caballero E, Ortiz de Lejarazu R, Rodes B, HIV-2/HTLV Spanish Study Group. 2002. Infection with retroviruses other than HIV-1 in Spain: A retrospective analysis for HIV-2, HTLV-I, and/or HTLV-II. HIV Clin Trials 3:397-402.
16. Toro C, Rodes B, Poveda E, Soriano V. 2003. Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor. Transplantation 75:102-104.
17. Tsurumi H, Tani K, Tsuruta T, Shirato R, Matsudaira T, Tojo A, Wada C, Uchida H, Ozawa K, Asano S. 1992. Adult T-cell leukemia developing during immunosuppressive treatment in a renal transplant recipient. Am J Hematol 41:292-294.
18. Williams NP, Buchner LM, Shah DJ, Williams W. 1994. Adult T-cell leukemia/lymphoma in a renal transplant recipient: An opportunistic occurrence. Am J Nephrol 14:226-229.
19. Zanke BW, Rush DN, Jeffery JR, Israels LG. 1989. HTLV-1 T cell lymphoma in a cyclosporine-treated renal transplant patient. Transplantation 48:695-697.